Due to the COVID-19 pandemic, the global Cefazolin Sodium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Cefazolin Sodium market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Cefazolin Sodium landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Antimicrobial Drugs accounting for % of the Cefazolin Sodium global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Adult segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.

The global major manufacturers of Cefazolin Sodium include Acs Dobfar Spa, Fresenius Kabi Anti-Infectives, Olon, Orchid, HPGC, CSPC, NCPC, LKPC and Qilu Antibiotics Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Cefazolin Sodium in 2022.

 

This report focuses on Cefazolin Sodium volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cefazolin Sodium market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

 

Global Cefazolin Sodium Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

Segment by Type

 

  • Antimicrobial Drugs
  • Antibiotic
  • Cephalosporins
  • First-Generation Cephalosporins

 

Segment by Application

 

  • Adult
  • Children

 

By Region

 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

 

By Company

 

  • Acs Dobfar Spa
  • Fresenius Kabi Anti-Infectives
  • Olon
  • Orchid
  • HPGC
  • CSPC
  • NCPC
  • LKPC
  • Qilu Antibiotics Pharmaceutical
  • Huarun Jiuxin
  • Hisun
  • Fukang
  • Sinopharm Sandwich


CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414